×
About 359 results

ALLMedicine™ Mycobacterium Kansasii Center

Research & Reviews  179 results

Population genomics provides insights into the evolution and adaptation to humans of th...
https://doi.org/10.1038/s41467-021-22760-6 10.1371/journal.pntd.0007083 10.1128/CMR.9.2.177 10.5588/ijtld.14.0120 10.1093/gbe/evv035 10.1016/S0272-5231(02)00016-3 10.1183/09031936.00149212 10.1016/j.jinf.2016.08.020 10.1186/s12890-018-0728-z 10.1371/journal.pone.0109736 10.1016/j.femsre.2005.02.001 10.1128/JCM.35.8.1959-1964.1997 10.1128/JCM.35.1.25-32.1997 10.1128/JCM.41.3.1240-1244.2003 10.1128/JCM.42.1.119-125.2004 10.1099/ijsem.0.003378 10.3389/fmicb.2019.02918 10.2166/wh.2014.161 10.1016/j.ijmm.2014.02.004 10.1016/S0041-3879(82)80050-0 10.1183/09031936.00066614 10.1126/science.aaf8156 10.1128/JB.82.4.517-527.1961 10.1128/JB.171.6.3465-3470.1989 10.1111/mmi.12387 10.1128/IAI.32.2.614-624.1981 10.1111/mmi.13971 10.1093/ajcp/23.4.363 10.1099/mic.0.000604 10.1016/j.chembiol.2011.12.016 10.1038/nrmicro.2016.131 10.1016/j.bbamcr.2013.11.003 10.1371/journal.pcbi.1004739 10.1038/ng.195 10.1128/MMBR.00018-13 10.1128/JB.01235-08 10.1371/journal.pone.0122804 10.1074/jbc.M111.336461 10.1038/nmicrobiol.2015.19 10.1186/1471-2164-8-60 10.1073/pnas.1400390111 10.1111/j.1365-2958.2006.05155.x 10.1371/journal.ppat.1000794 10.1242/dmm.006676 10.1898/NWN15-22.1 10.1093/infdis/jiaa187 10.3389/fcimb.2020.00122 10.1378/chest.75.2.120 10.1080/00420988620080351 10.3109/1040841X.2010.482923 10.1038/s41598-017-05916-7 10.1126/sciadv.aat5869 10.1073/pnas.1804555115 10.1128/JB.00359-16 10.1128/JB.01190-06 10.1111/j.1574-6968.2008.01320.x 10.1038/s41598-018-35012-3 10.1128/JB.172.6.3003-3008.1990 10.1046/j.1365-2958.1998.00832.x 10.1074/jbc.M113.525550 10.1038/nrmicro.2015.13 10.1128/AEM.68.11.5318-5325.2002 10.1128/JCM.31.10.2769-2772.1993 10.1093/bioinformatics/btu170 10.1002/cpbi.102 10.1093/bioinformatics/btt086 10.1038/s41467-018-07641-9 10.1093/bioinformatics/btv421 10.1093/bioinformatics/btu153 10.1093/bioinformatics/bty121 10.1093/bioinformatics/btu033 10.1093/nar/gkz239 10.1093/molbev/msj030 10.1093/molbev/msu136 10.1093/molbev/mst028 10.1093/molbev/msx066 10.1093/nar/gku1196 10.1093/bioinformatics/bty191 10.1186/1471-2105-10-421 10.1093/bioinformatics/btx610 10.1038/nmeth.1923 10.1093/bioinformatics/btp352 10.1101/gr.129684.111 10.1093/oxfordjournals.molbev.a026036 10.1093/molbev/msz257 10.1093/ve/vew007 10.1111/1755-0998.12603 10.1093/ve/vey016 10.1093/sysbio/syy032 10.1093/ve/vex042 10.1093/bioinformatics/btv433
Nature Communications; Luo T, Xu P et. al.

May 4th, 2021 - Mycobacterium kansasii can cause serious pulmonary disease. It belongs to a group of closely-related species of non-tuberculous mycobacteria known as the M. kansasii complex (MKC). Here, we report a population genomics analysis of 358 MKC isolates...

Determination of Clinical Characteristics of Mycobacterium kansasii-Derived Species by ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041593
Annals of Laboratory Medicine; Kim YG, Lee HY et. al.

Apr 7th, 2021 - Seven genotypic subtypes of Mycobacterium kansasii were recently demonstrated to represent distinct species based on phylogenomic analysis. Mycobacterium kansasii sensu stricto (formerly known as subtype 1) is most frequently associated with human...

Drug susceptibility distributions of Mycobacterium chimaera and other non-tuberculous m...
https://doi.org/10.1128/AAC.02131-20
Antimicrobial Agents and Chemotherapy; Schulthess B, Schäfle D et. al.

Feb 23rd, 2021 - Recent outbreaks of cardiac surgery-associated Mycobacterium chimaera infections have highlighted the importance of species differentiation within the Mycobacterium avium complex and pointed to a lack of antibiotic susceptibility data for M. chima...

Nouveau short-course therapy and morphism mapping for clinical pulmonary Mycobacterium ...
https://doi.org/10.1128/AAC.01553-20
Antimicrobial Agents and Chemotherapy; Srivastava S, Wang JY et. al.

Feb 9th, 2021 - Standard therapy [isoniazid, rifampin, ethambutol], with or without a macrolide, for pulmonary Mycobacterium kansasii lasts more than a year. Therefore, shorter treatment duration regimens are required. We used data from 32 Taiwanese patients trea...

Mycobacterium kansasii Infection Presenting as an Invasive Endobronchial Occupancy.
https://doi.org/10.1089/aid.2020.0141
AIDS Research and Human Retroviruses; Guan Y, Bai D et. al.

Nov 10th, 2020 - Mycobacterium kansasii Infection Presenting as an Invasive Endobronchial Occupancy.|2020|Guan Y,Bai D,Wang C,Liu Y,|

see more →

Clinicaltrials.gov  179 results

Population genomics provides insights into the evolution and adaptation to humans of th...
https://doi.org/10.1038/s41467-021-22760-6 10.1371/journal.pntd.0007083 10.1128/CMR.9.2.177 10.5588/ijtld.14.0120 10.1093/gbe/evv035 10.1016/S0272-5231(02)00016-3 10.1183/09031936.00149212 10.1016/j.jinf.2016.08.020 10.1186/s12890-018-0728-z 10.1371/journal.pone.0109736 10.1016/j.femsre.2005.02.001 10.1128/JCM.35.8.1959-1964.1997 10.1128/JCM.35.1.25-32.1997 10.1128/JCM.41.3.1240-1244.2003 10.1128/JCM.42.1.119-125.2004 10.1099/ijsem.0.003378 10.3389/fmicb.2019.02918 10.2166/wh.2014.161 10.1016/j.ijmm.2014.02.004 10.1016/S0041-3879(82)80050-0 10.1183/09031936.00066614 10.1126/science.aaf8156 10.1128/JB.82.4.517-527.1961 10.1128/JB.171.6.3465-3470.1989 10.1111/mmi.12387 10.1128/IAI.32.2.614-624.1981 10.1111/mmi.13971 10.1093/ajcp/23.4.363 10.1099/mic.0.000604 10.1016/j.chembiol.2011.12.016 10.1038/nrmicro.2016.131 10.1016/j.bbamcr.2013.11.003 10.1371/journal.pcbi.1004739 10.1038/ng.195 10.1128/MMBR.00018-13 10.1128/JB.01235-08 10.1371/journal.pone.0122804 10.1074/jbc.M111.336461 10.1038/nmicrobiol.2015.19 10.1186/1471-2164-8-60 10.1073/pnas.1400390111 10.1111/j.1365-2958.2006.05155.x 10.1371/journal.ppat.1000794 10.1242/dmm.006676 10.1898/NWN15-22.1 10.1093/infdis/jiaa187 10.3389/fcimb.2020.00122 10.1378/chest.75.2.120 10.1080/00420988620080351 10.3109/1040841X.2010.482923 10.1038/s41598-017-05916-7 10.1126/sciadv.aat5869 10.1073/pnas.1804555115 10.1128/JB.00359-16 10.1128/JB.01190-06 10.1111/j.1574-6968.2008.01320.x 10.1038/s41598-018-35012-3 10.1128/JB.172.6.3003-3008.1990 10.1046/j.1365-2958.1998.00832.x 10.1074/jbc.M113.525550 10.1038/nrmicro.2015.13 10.1128/AEM.68.11.5318-5325.2002 10.1128/JCM.31.10.2769-2772.1993 10.1093/bioinformatics/btu170 10.1002/cpbi.102 10.1093/bioinformatics/btt086 10.1038/s41467-018-07641-9 10.1093/bioinformatics/btv421 10.1093/bioinformatics/btu153 10.1093/bioinformatics/bty121 10.1093/bioinformatics/btu033 10.1093/nar/gkz239 10.1093/molbev/msj030 10.1093/molbev/msu136 10.1093/molbev/mst028 10.1093/molbev/msx066 10.1093/nar/gku1196 10.1093/bioinformatics/bty191 10.1186/1471-2105-10-421 10.1093/bioinformatics/btx610 10.1038/nmeth.1923 10.1093/bioinformatics/btp352 10.1101/gr.129684.111 10.1093/oxfordjournals.molbev.a026036 10.1093/molbev/msz257 10.1093/ve/vew007 10.1111/1755-0998.12603 10.1093/ve/vey016 10.1093/sysbio/syy032 10.1093/ve/vex042 10.1093/bioinformatics/btv433
Nature Communications; Luo T, Xu P et. al.

May 4th, 2021 - Mycobacterium kansasii can cause serious pulmonary disease. It belongs to a group of closely-related species of non-tuberculous mycobacteria known as the M. kansasii complex (MKC). Here, we report a population genomics analysis of 358 MKC isolates...

Determination of Clinical Characteristics of Mycobacterium kansasii-Derived Species by ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041593
Annals of Laboratory Medicine; Kim YG, Lee HY et. al.

Apr 7th, 2021 - Seven genotypic subtypes of Mycobacterium kansasii were recently demonstrated to represent distinct species based on phylogenomic analysis. Mycobacterium kansasii sensu stricto (formerly known as subtype 1) is most frequently associated with human...

Drug susceptibility distributions of Mycobacterium chimaera and other non-tuberculous m...
https://doi.org/10.1128/AAC.02131-20
Antimicrobial Agents and Chemotherapy; Schulthess B, Schäfle D et. al.

Feb 23rd, 2021 - Recent outbreaks of cardiac surgery-associated Mycobacterium chimaera infections have highlighted the importance of species differentiation within the Mycobacterium avium complex and pointed to a lack of antibiotic susceptibility data for M. chima...

Nouveau short-course therapy and morphism mapping for clinical pulmonary Mycobacterium ...
https://doi.org/10.1128/AAC.01553-20
Antimicrobial Agents and Chemotherapy; Srivastava S, Wang JY et. al.

Feb 9th, 2021 - Standard therapy [isoniazid, rifampin, ethambutol], with or without a macrolide, for pulmonary Mycobacterium kansasii lasts more than a year. Therefore, shorter treatment duration regimens are required. We used data from 32 Taiwanese patients trea...

Mycobacterium kansasii Infection Presenting as an Invasive Endobronchial Occupancy.
https://doi.org/10.1089/aid.2020.0141
AIDS Research and Human Retroviruses; Guan Y, Bai D et. al.

Nov 10th, 2020 - Mycobacterium kansasii Infection Presenting as an Invasive Endobronchial Occupancy.|2020|Guan Y,Bai D,Wang C,Liu Y,|

see more →

News  1 results

Cutaneous Infection With Mycobacterium kansasii in a Patient With Myelodysplastic Syndrome and Sweet Syndrome
https://www.mdedge.com/dermatology/article/101110/contact-dermatitis/cutaneous-infection-mycobacterium-kansasii-patient/page/0/1

Jul 7th, 2015 - The unpredictable presentation of cutaneous M kansasii infection coupled with the variable history necessitates a high level of clinical suspicion and a low threshold for culturing lesions. Furthermore, the long duration and complexity of the anti.

see more →